sb.scorecardresearch
Advertisement

Published 18:01 IST, February 12th 2024

GSK Pharma’s Q3 profit dips marginally to Rs 229 crore

GSK endured a decline in revenue for three consecutive quarters following the implementation of the NLEM.

Reported by: Business Desk
Follow: Google News Icon
  • share
Top 10 Pharmaceutical Companies in India by Market Capitalisation
Top 10 Pharmaceutical Companies in India by Market Capitalisation | Image: Unsplash
Advertisement

18:01 IST, February 12th 2024